Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yu Ping Feng Granule for children with recurrent respiratory tract infections
ChiCTR-IPR-15006847Phase 4Completed
- Sponsor
- Beijing Children's Hospital
- Start
- Sep 2014
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of yupingfeng in Airways Infection (3 arms), sponsored by Beijing Children's Hospital. Primary endpoint: RRTI cure rate. Started Sep 2014; status: completed.
02
Drugs
yupingfeng
03
Conditions
Airways Infection
Beyond the preview
Go deeper on ChiCTR-IPR-15006847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006847.